A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 16 charts
BRIDGE
Phase 2 Terminated
10 enrolled
ELEVATE HNSCC
Phase 2 Terminated
193 enrolled 27 charts
CARMEN-LC05
Phase 2 Terminated
57 enrolled 26 charts
PersoMed-I
Phase 2 Terminated
20 enrolled
PRESERVE3
Phase 2 Terminated
92 enrolled 24 charts
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
Phase 2 Terminated
1 enrolled
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
Phase 2 Terminated
17 enrolled
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma
Phase 2 Terminated
10 enrolled
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer
Phase 2 Terminated
6 enrolled 13 charts
Phalcis
Phase 2 Terminated
57 enrolled 18 charts
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
Phase 2 Terminated
17 enrolled 12 charts
EPIC
Phase 2 Terminated
4 enrolled 6 charts
AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer
Phase 2 Terminated
4 enrolled 9 charts
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer
Phase 2 Terminated
9 enrolled 4 charts
Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer
Phase 2 Terminated
7 enrolled 9 charts
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
Phase 2 Terminated
3 enrolled 8 charts
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
Phase 2 Terminated
1 enrolled 10 charts
TELE-ABC
Phase 2 Terminated
53 enrolled 47 charts
A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma
Phase 2 Terminated
9 enrolled
Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial
Phase 2 Terminated
70 enrolled
Efficacy and Safety of OncoGelâ„¢ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
Phase 2 Terminated
137 enrolled 9 charts
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Terminated
35 enrolled
Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer
Phase 2 Terminated
11 enrolled 8 charts
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)
Phase 2 Terminated
5 enrolled 5 charts
UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
Phase 2 Terminated
20 enrolled 7 charts
Biochemotherapy With Temozolomide for Metastatic Melanoma
Phase 2 Terminated
5 enrolled 5 charts
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
Phase 2 Terminated
9 enrolled 4 charts
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Phase 2 Terminated
50 enrolled 9 charts
ARTEMIS
Phase 2 Terminated
124 enrolled 10 charts
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC
Phase 2 Terminated
4 enrolled
Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Terminated
59 enrolled 16 charts
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase 2 Terminated
32 enrolled 6 charts
J10130
Phase 2 Terminated
31 enrolled 11 charts
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
Phase 2 Terminated
87 enrolled 13 charts
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
Phase 2 Terminated
19 enrolled 4 charts
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
Phase 2 Terminated
7 enrolled 9 charts
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
Phase 2 Terminated
3 enrolled 9 charts
NA_00067809
Phase 2 Terminated
3 enrolled 5 charts
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
Phase 2 Terminated
6 enrolled 12 charts
Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer
Phase 2 Terminated
170 enrolled
IPEC-GC
Phase 2 Terminated
30 enrolled
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 2 Terminated
47 enrolled
Gem-ox
Phase 2 Terminated
33 enrolled 9 charts
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes
Phase 2 Terminated
4 enrolled
PGA
Phase 2 Terminated
7 enrolled 1 chart
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Phase 2 Terminated
76 enrolled 13 charts